Abstract
related signaling pathway is the major regulator of growth and body size. DBL-1, the BMP-23 related ligand, is secreted by neurons and body wall muscle, and acts as a dose-dependent 24 regulator of body size. We investigated the transcriptional network through which the DBL-25 1/BMP pathway regulates body size and identified cuticle collagen genes as major effectors of 26 growth control. Here we demonstrate that cuticle collagen genes can act as positive regulators 27 (col-41), dose-sensitive regulators (rol-6), and negative regulators (col-141, col-142) of body 28 size. Moreover, we show requirement of DBL-1/BMP signaling for stage-specific expression of 29 cuticle collagen genes. We used chromatin immunoprecipitation followed by high throughput 30 sequencing (ChIP-Seq) and electrophoretic mobility shift assays to show that the Smad signal 31 transducers directly associate with conserved Smad binding elements in regulatory regions of 32 col-141 and col-142, but not of col-41. Hence, cuticle collagen genes are directly and indirectly 33 regulated via the DBL-1/BMP pathway. These results provide the first direct regulatory link 34 between this conserved signaling pathway and the collagen genes that act as its downstream 35 effectors in body size regulation. Since collagen mutations and misregulation are implicated in 36 numerous human genetic disorders and injury sequelae, understanding how collagen gene 37 expression is regulated has broad implications. 38 39 40
Introduction

55
The Transforming Growth Factor-beta (TGF-β) superfamily encompasses more than 30 56 ligands including Bone Morphogenetic Proteins (BMPs), Activin, and Nodal. BMPs play 57 essential roles in development and have been studied in a variety of contexts [1] . The roles of 58
BMPs in growth and body size regulation, however, are relatively unexplored. This deficit is 59 partly due to body size being expressed as a complex trait with continuous variation. The 60 existence of monogenic variants with discrete body size changes provides us with an entry point 61 into growth and size regulating mechanisms. We have capitalized on the major visible effect of 62 BMP signaling on growth regulation in the nematode Caenorhabditis elegans to uncover 63 110 111
Results
112
Cuticle collagen genes are transcriptional targets of the DBL-1 pathway and are required 113 for normal body size. 114
We sought to connect the DBL-1 transcriptional program to its downstream effectors of 115 body size regulation. In previous work, we identified five putative target genes with body size 116 phenotypes [23] , but all of these genes encode signaling molecules or transcription factors, so 117 they are not the downstream effectors of growth control. It has been proposed that changes in 118 hypodermal polyploidy contribute to the reduced growth of dbl-1 mutant adults [27] , although 119 these changes cannot account for differences in size during larval stages. We tested the functions 120 of putative target genes encoding DNA licensing factors and cyclins that could regulate 121 polyploidization, but knockdown of these genes by RNAi did not produce body size phenotypes 122 (S1 Fig). We next turned our attention to four cuticle collagen genes that we identified as 123 putative transcriptional targets of the DBL-1 pathway. We performed qRT-PCR to verify 124 transcriptional changes in cuticle collagen genes. We compared expression in dbl-1 and sma-3 125 mutants to wild-type controls at the second larval (L2) stage, the same stage in which the 126 microarray analysis had been conducted. In absence of DBL-1 signaling, rol-6 and col-41 are 127 down regulated while col-141 and col-142 are up-regulated ( We hypothesized that regulated expression of these cuticle collagen genes contributes to 140 body size regulation. An alternative hypothesis is that the altered expression of cuticle collagen 141 genes is a response to, rather than a cause of, the altered size of dbl-1 mutants [28] . To address 142 the role of these cuticle collagen genes in body size regulation, we performed RNAi of col-41, 143 rol-6, and col-141 and measured body length at different time points during larval and adult 144 growth ( Fig 1A) . RNAi of col-41 and rol-6 led to a decrease in body size at all stages. 145
Conversely, col-141 RNAi led to a transient increase in body size in the larval stages, suggesting 146 that cuticle collagens can act as negative as well as positive regulators of body size. We verified 147 our results using an available loss-of-function mutation in rol-6. This rol-6(lf) mutant also has a 148 small body size, as illustrated by body length measured at the L4 stage (Fig 1B) . 149
If cuticle collagen expression is truly instructive rather than permissive for body size 150 regulation, we would expect that overexpression of respective collagens should also lead to body 151 size changes. Therefore, we performed overexpression of col-141 and col-142, by increasing 152 copy number in transgenics carrying a genomic fragment that contains both genes, which are 153 adjacent in the genome. Overexpression of col-141 and col-142 resulted in decreased body size 154 relative to wild-type worms (Fig 1B) , confirming these genes as negative regulators of growth. 155
We performed a similar experiment to overexpress rol-6. Surprisingly, overexpression of rol-6 156 led to a decrease, rather than an increase, in body size (Fig 1C) . To confirm that the observed 157 phenotypes were due to rol-6 overexpression, rather than an artifact of the transgene, we 158 performed rol-6 RNAi on the overexpression lines to reduce the level of overexpression. This 159
RNAi inhibition of rol-6 expression ameliorated the decreased body size in the overexpressing 160 lines (Fig 1C) . These results suggest that rol-6 is dose-sensitive and must be expressed in a 161 particular range; otherwise aberrant body size and morphological defects are observed. To identify which transcriptional targets of DBL-1 signaling were potentially directly 166 regulated by Smad binding, genome-wide ChIP-seq was performed using a strain expressing 167 functional GFP::SMA-3 from the endogenous sma-3 promoter, in a sma-3(wk30) background. 168
Using the Galaxy software [29-31], we extracted genomic sequences from the coordinates 169 obtained via ChIP-seq. MEME-ChIP software [32] was used to discover enriched motifs and 170 generate logo plots. The top two enriched motifs were the CTGCGTCT SBE and GAGA (Fig  171   2A ). The presence of GTCT as an enriched motif indicates an increased presence of SMA-3 at 172 the indicated association sites. Among the cuticle collagen genes that we established as 173 transcriptional targets, the intergenic region between col-141 and col-142 had strong Smad 174 binding ( Fig 2B) . No additional SMA-3 recruitment sites were identified in this genomic region, 175
suggesting that the intergenic region serves to regulate both of these genes. We therefore chose 176 to study this region, which we will refer to hereafter as col-p. Further analysis of col-p revealed 177 multiple SBEs that are conserved between three related nematode species (Fig 3A) . 178 179 Cuticle collagen genes may be direct or indirect targets of DBL-1 Smads. 180
In order to elucidate the molecular requirements for Smad recruitment, we used the 181 electrophoretic mobility shift assay (EMSA) to test R-Smad SMA-3 and co-Smad SMA-4 for 182 binding. We generated four probes for EMSA based on sequence alignment and the presence of 183 GTCT sequences ( Fig 4C) . SMA-4 strongly and specifically bound to probes 3 and 4 ( Fig 4A- (Fig 5A-C expression, we further crossed these lines into sma-3 mutant background. We observed little to 201 no expression of mCherry expression at all stages (Fig 5D-F) . We quantitated fluorescence 202 intensity and found that it was significantly reduced (Fig 5G) . This result did not align with our 203 microarray and qRT-PCR results, which showed increased rather than decreased expression of 204 col-141 and col-142 in DBL-1 pathway mutants. However, those assays were conducted at the 205 L2 stage, at which time fluorescence of our reporter is undetectable. As described below, qRT-206 PCR experiments in adult animals are consistent with our reporter results. 207
To test if SBEs present in col-p are relevant for mCherry expression, we made transgenic 208 animals with mutated SBEs (mt.col-p) driving 2xNLS::mCherry. We noted complete loss of 209 mCherry expression except in the vulva (Fig 5J) , indicating Smad binding at these SBEs is 210 required for gene expression in the hypodermis (Fig 5H-I) . In order to test if mCherry expression 211 was the same in the presence and absence of sma-3, we crossed these worms into sma-3 mutant 212 background (Fig 5K-M) . Again, we observed a complete absence of fluorescence. 213
To verify the results from our extrachromosomal reporter, we wanted to study the 214 expression of col-141 in its endogenous genomic environment. Utilizing CRISPR-Cas9, we 215 knocked in 2xNLS::GFP to replace col-141 making a transcriptional reporter and a loss of 216 function simultaneously (Fig 6A) . We characterized the reporter and observed that GFP 217 expression is only visible at the adult stage in the hypodermis alone (Fig 6B-D) , with little to no 218 expression observed in larval stages, consistent with the result from the extrachromosomal 219 reporter. To confirm whether DBL-1 signaling transcriptionally regulated GFP expression, we 220 crossed the col-141 reporter into a sma-3 mutant background (Fig 6E-G) . We observed a loss of 221 GFP expression, replicating the results of the extrachromosomal col-p::2xNLSmCherry 222 transgenic animals (Fig 5A,D) . 223
This genome-edited animal also allowed us to determine the body size phenotype of 224 col-141(lf) and compare it to col-141(RNAi). We measured body length of col-141(lf) at L2, L4, 225
and adult stages and found that it is longer than controls at all three stages (Fig 5H, S2) , similar 226 to the RNAi results (Fig 1A) except that body length differences persisted into adulthood in the 227 mutants. Since col-141 shares sequence homology with col-142, we wondered if there could be 228 partial functional redundancy between the two genes. We therefore performed RNAi targeting 229 col-142 on the col-141(lf) mutant and observed a further increase in body size in adults 230 compared to col-141(lf) alone, and compared to wild type (Fig 5H) . (Table 1) . Meanwhile, ) strains showed a reduction of expression at 237 the adult stage.
In order to confirm that loss of fluorescence expression in col-238 141 (lf[2xNLS::gfp] ) and col-p::2xNLSmCherry replicated col-141 and col-142 expression in 239 sma-3 mutant background, we performed qRT-PCR on sma-3 mutant adults. We observed a 240 significant decrease in col-141 and col-142 levels in sma-3 mutant adults (Table 1) , 241 corroborating the observations from our transcriptional reporters. Therefore, the direction of 242 action of the DBL-1 pathway on col-141 and col-142 expression is stage-specific. We extended 243 these observations by determining the expression levels of col-41 and rol-6 in sma-3 mutant 244 adults. In these experiments, we observed an increase in col-41 and rol-6 levels ( identified that contribute to body size regulation; however, the effector genes for body size 253 regulation through those pathways are poorly characterized. We have capitalized on the genetic 254 tractability of C. elegans to study how the conserved DBL-1 BMP-related signaling pathway 255 regulates body size. In our work, we elucidated the transcriptional network initiated by DBL-1 to 256 explain how body size is modulated by DBL-1 activity. We have shown that cuticle collagen 257 genes are transcriptional targets of the DBL-1 pathway via microarray analysis and qRT-PCR. 258
Moreover, we showed that DBL-1 is required for stage-specific expression of cuticle collagen 259 genes. Through RNAi, mutant, and overexpression studies we discovered a positive regulator 260 (col-41), a dose-sensitive regulator (rol-6) and negative regulators (col-141, col-142) of body 261 size. We showed association of Smads in the intergenic region between col-141 and col-142 via 262
ChIP-seq and using EMSA we showed in vitro binding of SMA-4 MH1 domain to conserved 263 SBE sites in this region. Additionally, we show lack of binding by Smads to the previously 264 defined col-41 promoter region. Hence, cuticle collagen genes are directly and indirectly 265 regulated via the DBL-1 pathway. Based on presented evidence, we conclude that cuticle 266 collagen genes are major effectors of body size through the DBL-1 pathway. We speculate that 267 the specific collagen isoforms deposited in the cuticle contribute to the characteristics of that 268 cuticle, due to differences in how they crosslink with other components. COL-41, as a positive 269 regulator of growth, may contribute to a more elastic, expandable cuticle. COL-141 and COL-270 142, as negative regulators of growth, may contribute to a more rigid, less easily expanded 271 cuticle. 272
Since cuticle collagen genes are encoded by such a large gene family in C. elegans, it is 273 reasonable to ask why so many genes are needed. One possible explanation is that the large 274 number of genes allows rapid synthesis of the cuticle during the discrete cuticle synthesis periods 275 of the worm's lifecycle. Our work supports the notion that there is also a degree of functional 276 specificity. Consistent with this hypothesis, more than 60% of cuticle collagen genes have been 277 In addition to highlighting the functional significance of collagen genes, our work sheds 299 light on the mechanisms of action of the DBL-1 Smads. Three Smads act in this pathway: the R-300 Smads SMA-2 and SMA-3 and the co-Smad SMA-4. All three Smads are necessary for pathway 301 function, and they presumably form a heterotrimeric complex. We performed genome-wide 302
ChIP-seq analysis on GFP::SMA-3 and identified GTCT, the canonical SBE, as enriched at sites 303 of SMA-3 occupancy. In Drosophila, Mad, the Dpp R-Smad, binds GC-rich Smad binding sites 304 termed GC-SBE (GGAGCC) [48] , while Medea, the Dpp co-Smad, binds canonical SBEs 305 (GTCT). In our analyses of targets of the DBL-1 pathway, we observed Smad binding to the 306 intergenic region between col-141 and col-142. We therefore tested for direct binding of isolated 307 MH1 domains of Smads SMA-3 and SMA-4 to SBEs in this region. Consistent with findings in 308 Drosophila, the MH1 domain of co-Smad SMA-4, but not that of R-Smads SMA-3, was able to 309 bind the SBE's directly in vitro. Similarly, the co-Smad of the C. elegans DAF-7/TGF-β 310 pathway, DAF-3, has previously been shown to bind canonical GTCT sequences [49] . Since 311 there is no evidence for direct binding of R-Smad SMA-3 to GTCT sequences, the enrichment of 312 this motif at SMA-3 genomic binding sites may be due to SMA-3 being recruited as part of the 313 Smad complex, with co-Smad SMA-4 making the direct contact with this site. 314
In conclusion, our work elucidates the transcriptional network for body size regulation 315 through the DBL-1/BMP pathway in C. elegans. We propose a model (Fig 7) in which DBL-1 316 signaling leads to Smad activation causing direct and indirect regulation of specific cuticle 317 collagen genes. This regulation occurs in a stage-specific manner to initiate the correct temporal 318 program of collagen gene expression. Inappropriate expression of cuticle collagen genes leads to 319 aberrant body size. This work thus provides the first mechanistic link between BMP signaling 320 and effectors of body size regulation. 321
322
Materials and Methods
323
RNA interference (RNAi) 324
RNAi by feeding was performed as described [50, 51] . RNAi clones that target the unique (non-325
Gly-X-Y repeat) regions of collagen genes were generated by cloning desired PCR fragments 326 into L4440. 327 328
Electrophoretic Mobility Shift Assay (EMSA) 329
Protein purification: GST tagged versions of the MH1 domains of SMA-2, SMA-3, and SMA-4 330 were cloned in the pGEX-4T2 vector. All three proteins were isolated using BL21 competent 331 cells, grown in a starter culture O/N at ‫.ܥ°73‬ From the starter culture a fresh culture of 100 ml 332 was started, grown at ‫ܥ°73‬ until O.D. of 500 was reached. Expression was induced using IPTG 333 at final concentration of 1 mM in 100 ml cultures and grown at 28°C for 6-8 hours. Standard 334 batch purification was performed using GST beads and eluted in 30 mM reduced glutathione and 335 50 mM Tris buffer, pH 8.0. Three elutions were taken, each of the primary elutions were run on 336 4-12% Bis-Tris gels (Life Technology) for size separation under denaturing conditions. EMSA 337
Gel Shifts: Double stranded probes were labeled with 32 P and incubated with protein in binding 338 buffer at RT for 20 minutes. Binding Buffer was composed of 50% glycerol, 100mM HEPES, 339 15mM DTT, 0.5mg/ml BSA, 0.5M KCl, 50mM ZnSO 4, 50 µg/ml dIdC, samples were run on 5% 340 native acrylamide gel for 1-1.5 hours, dried for one hour at 65°C and developed for 1 hour at -341 80°C. Probe 1: ttcaaaataagacaacacagaaagtagggt. Probe 2: tgaccttttcatgatcataagacccggttt. Probe 3: 342 acggtttcaaggtctgtctcctcgaacacg. Probe 4: ggtgagacaagcaatgagaatagacacaca. 343 344
qRT-PCR 345
Worms were grown at 20°C until a large amount of eggs were observed on plates. Worms were 346 then washed off using M9 buffer and the remaining eggs were allowed to hatch for 4 hours. 347
Worms were then collected and placed on new plates and grown at 20°C until late L2 or adult 348 stage, collected and mRNA was extracted using the RNeasy mini kit (Qiagen). Reverse 349 transcriptase PCR and quantitative real time PCR were performed as previously described [52] . An independently generated transgenic line gave equivalent results. OE-overexpression; Control-554 Empty Vector. Error bars show standard error. * P < 0.05, ** P < 0.005, ***P < 0.0005. 
